Amundi Prime Europe UCITS ETF DR (C) is an exchange-traded fund that tracks the Solactive GBS Developed Markets Europe All Cap Index, providing broad exposure to large and mid-cap stocks across 15 developed European countries. Launched on January 15, 2020, and domiciled in Luxembourg, this accumulating ETF reinvests dividends rather than distributing them, enhancing long-term compounding for investors. With a low total expense ratio of 0.05% per annum and a fund size of approximately 170 million euros, it offers cost-efficient access to a diversified portfolio spanning key sectors including financial services, industrials, healthcare, consumer defensive, and technology. Top holdings feature prominent companies like ASML Holding, Nestle, SAP, AstraZeneca, and Roche, representing about 20% of assets and reflecting Europe's economic leaders in semiconductors, consumer goods, software, pharmaceuticals, and more. Compliant with UCITS regulations, the ETF ensures high standards of transparency, liquidity, and investor protection, unhedged against currency risk in euros. It plays a vital role in the financial markets by enabling efficient participation in European equity growth without active stock selection.